You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Breast cancer

Guidance on the use of trastuzumab for the treatment of advanced breast cancer

  • Technology appraisal guidance
  • Reference number: TA34
  • Published:  15 March 2002
  • Guidance
  • Tools and resources
  • Information for the public
  • History
Download guidance (PDF)
  • Overview
  • 1 Recommendations
  • 2 Clinical need and practice
  • 3 The technology
  • 4 Evidence
  • 5 Implications for the NHS
  • 6 Further research
  • 7 Implementation
  • 8 Appraisal committee members
  • 9 Sources of evidence
  • Update information

6 Further research

6.1

Information linking side effects associated with treatments with quality of life would enhance the comprehensiveness of future economic evaluations of treatments for advanced breast cancer.


Next page 7 Implementation Previous page 5 Implications for the NHS